News Drug Formulary Safety Net Resources
Drug Formulary Categories and Charges Search HA Drug Formulary Self-financed Drugs Available for Purchase by Patients at HA Pharmacy How we evaluate new drugs Governance Drug Management Committee Drug Advisory Committee Drug Formulary Committee Drug & Therapeutics Committee Drug Selection Committee Expert Panel Medication Safety Committee Samaritan Fund Community Care Fund Drug Education HA Drug Formulary Management Manual Frequently Asked Questions Useful Links
HA Drug Formulary
Version 21.3 – with effect from 31 January 2026
  1. The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand.
  2. Some drugs may appear in more than one category due to different formulations and/or indications.
  3. The "Special" drugs will be prescribed as clinically indicated based on the specified indications.
  4. Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed on the HA Drug Formulary.
Drug classes
Result of:
Endocrine
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
Endocrine
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
DRUGS USED IN DIABETES
DEXTROSE ACARBOSE
DIAZOXIDE ALOGLIPTIN
GLICLAZIDE ALOGLIPTIN + PIOGLITAZONE
GLIMEPIRIDE BIPHASIC INSULIN ASPART
GLIPIZIDE BIPHASIC INSULIN LISPRO
GLUCAGON DAPAGLIFLOZIN
INSULIN HUMAN (HUMULIN/ MIXTARD) DAPAGLIFLOZIN + METFORMIN
INSULIN ISOPHANE HUMAN DULAGLUTIDE
INSULIN NEUTRAL HUMAN EMPAGLIFLOZIN
METFORMIN EMPAGLIFLOZIN + METFORMIN
EXENATIDE
INSULIN ASPART HUMAN
INSULIN DEGLUDEC
INSULIN DEGLUDEC + ASPART
INSULIN DEGLUDEC + LIRAGLUTIDE
INSULIN DETEMIR
INSULIN GLARGINE
INSULIN GLARGINE + LIXISENATIDE
INSULIN GLULISINE
INSULIN LISPRO HUMAN
LINAGLIPTIN
LINAGLIPTIN + METFORMIN
LIRAGLUTIDE (SAXENDA)
LIRAGLUTIDE (VICTOZA)
METFORMIN
PIOGLITAZONE
PIOGLITAZONE + METFORMIN
SAXAGLIPTIN
SAXAGLIPTIN + METFORMIN
SEMAGLUTIDE
SITAGLIPTIN
SITAGLIPTIN + METFORMIN
VILDAGLIPTIN
VILDAGLIPTIN + METFORMIN
THYROID AND ANTITHYROID DRUGS
CARBIMAZOLE
IODINE + POTASSIUM IODIDE
LIOTHYRONINE
METHIMAZOLE
PROPYL THIOURACIL
THYROXINE
CORTICOSTEROIDS
BETAMETHASONE
DEXAMETHASONE
FLUDROCORTISONE
HYDROCORTISONE
METHYLPREDNISOLONE
PREDNISOLONE
TRIAMCINOLONE ACETONIDE
SEX HORMONES
ESTRADIOL (VAGINAL) ACTIVELLE (OR EQUIV) PROGESTERONE (VAGINAL)
ETHINYLOESTRADIOL DIENOGEST TIBOLONE
MEDROXYPROGESTERONE ACETATE DYDROGESTERONE
NORETHISTERONE FEMOSTON (OR EQUIV)
OESTROGENS CONJUGATED FINASTERIDE (PROSCAR) (OR EQUIV)
SUSTANON (OR EQUIV) KLIOGEST (OR EQUIV)
TESTOSTERONE (TOPICAL) NOVOFEM (OR EQUIV)
TESTOSTERONE ENANTHATE OESTRADIOL
TESTOSTERONE UNDECANOATE OESTROGEL (OR EQUIV)
OESTROGENS CONJUGATED
PROGESTERONE
PROGESTERONE (VAGINAL)
RALOXIFENE
TRISEQUENS (OR EQUIV)
HYPOTHALAMIC AND PITUITARY HORMONES AND ANTI-OESTROGENS
CLOMIPHENE CHORIOGONADOTROPIN ALFA SOMATROPIN CORIFOLLITROPIN ALFA
CORTICORELIN (HUMAN) DESMOPRESSIN (DDAVP) TOLVAPTAN (JINARC) FOLLITROPIN ALFA
DESMOPRESSIN (DDAVP) HUMAN CHORIONIC GONADOTROPHIN LUTROPIN ALFA
PROTIRELIN MENOTROPHIN TOLVAPTAN (JINARC)
TERLIPRESSIN SOMATROPIN
TETRACOSACTIDE THYROTROPIN ALFA
VASOPRESSIN TOLVAPTAN (SAMSCA)
DRUGS AFFECTING BONE METABOLISM
ZOLEDRONIC ACID (ZOMETA) ALENDRONATE ALENDRONATE + CHOLECALCIFEROL
CLODRONATE DENOSUMAB (PROLIA)
DENOSUMAB (PROLIA) IBANDRONIC ACID (BONDRONAT)
DENOSUMAB (XGEVA)
IBANDRONIC ACID (BONVIVA)
PAMIDRONATE
RISEDRONATE
ROMOSOZUMAB
SALCATONIN
SALCATONIN (NASAL)
TERIPARATIDE
ZOLEDRONIC ACID (ACLASTA)
OTHER ENDOCRINE DRUGS
BROMOCRIPTINE CABERGOLINE
DANAZOL CETRORELIX
METYRAPONE GANIRELIX
QUINAGOLIDE
MISCELLANEOUS (ENDOCRINE SYSTEM)
UREA (POWDER)